Glyph.

Exploring clinical concepts in multimodal data at Stanford Medicine

Scroll to explore

Concept network

Scroll to explore. Click any dot for its association wheel.

Discovered from20,391 discovery + 45,139 test CTs22.4M report tokens3.77M lab values16,553 ICD codes
Loading the graph
Sepsis
Display options
Color by
Full screen ↗

Risk markers for Sepsis

Widespread risk markers for sepsis 1–4 years after CT.

Risk markers for Heart failure (HFpEF)

More clustered, yet distributed, risk markers 1–4 years after CT.

Risk markers for Primary liver cancer

More tightly clustered risk markers 1–4 years after CT.

You ask Glyph

What are risk markers of primary liver cancer?

Labs · reports · CT

Risk markers for Primary liver cancer

Cholestasis in labs, cirrhotic morphology in reports, and liver/biliary findings on CT.

Associated conceptsOR
L108Cholestasis
2.57
R85Cirrhotic liver morphology
2.45
I87Hepatobiliary pattern
2.94

Unadjusted OR per SD · Discovery Site

Risk markers for Heart failure (HFpEF)

Renal and cardiovascular signs associated with later HFpEF.

You ask Glyph

What are renal risk markers of heart failure?

Laboratory findings

Renal risk markers for Heart failure (HFpEF)

Renal dysfunction sits alongside metabolic and coagulation abnormalities.

Associated conceptsOR
L84Azotemia
1.59
L62Renal dysfunction and acidosis
1.41
L87Coagulopathy with renal impairment
1.55

Unadjusted OR per SD · Discovery Site

You ask Glyph

What are risk markers of heart failure?

CT · reports

Cardiovascular risk markers for Heart failure (HFpEF)

Aortic disease, cardiac calcification and cardiomegaly cluster nearby.

Associated conceptsOR
I26Aortic atherosclerosis
1.87
I109Abdominal aortic calcification
1.74
R21Coronary / valve calcification
1.58
R204Cardiomegaly
1.26

Unadjusted OR per SD · Discovery Site

Explore another outcome

Choose a disease, or continue to the literature examples.

Concepts complement clinical literature

Compare Glyph concepts with published risk markers. Click any marker for details.

Abdominal CT and laboratory risk markersOnset of heart failure with preserved ejection fraction

Open figure ↗
20102015202020252026 · Glyph0.60.81.01.21.41.61.8Publication yearOdds Ratio*Prior hypertensionPrior diabetesBMISmoking risk indexHemoglobin <11 g/dLeGFR risk indexGlucose proxyTroponin I proxyLower HDL cholesterolWhite blood cellsHbA1cFibrinogenLower glucosedisposalNT-proBNPLower albuminTriglycerides / HDLLower ferritinCRP proxyReported steatosisD-dimerI87HepatobiliarypatternI26Aortic plaqueL127MultilineagecytopeniaL84AzotemiaI106Atherosclerosis/ colonicpathologyI65SplenomegalyL108CholestasisR85CirrhosisL87Coagulopathy /renalimpairmentL61Low haemoglobinPUBLISHED LITERATURE · AUROC 0.824WITH GLYPH · AUROC 0.854(+3.6% relative improvement)● Represented in literature● Beyond literature markers△ Closest Phecode matchLam et al.“Organ dysfunctionbefore heart failure”Circulation (314 cites)Ho et al.“Predictors of new-onset heart failure”Circ HF (380 cites)Eaton et al.“Risk factors forincident HFpEF”Circ HF (219 cites)de Boer et al.“Biomarkers andincident HF subtypes”JAMA Cardiol (261 cites)Savji et al.“Obesity andcardiometabolictraits”JACC HF (498 cites)Gong et al.“Risk factors forincident HF subtypes”Open Heart (62 cites)Fudim et al.“NAFLD and heartfailure risk”JAHA (96 cites)Zhao et al.“Subclinical riskfactors for HF”JAMA NO (8 cites)Ding et al.“Smoking and heartfailure subtypes”J Am Coll Cardiol (74 cites)Aboelsaad et al.“Ferritin and incidentheart failure”JACC HF (9 cites)Pandey et al.“HDL parameters andheart failure”JACC HF (15 cites)Cheng et al.“Kidney function andincident HF”JAHA (7 cites)Bukhari et al.“Glucose disposal andincident HF”JAHA (0 cites)

* Adjusted for patient age, sex, and recorded race; per Discovery-site SD. N = 5,253 studies.

References (13)
  1. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.
  2. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.
  3. Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women.
  4. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
  5. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.
  6. Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort.
  7. Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.
  8. Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults.
  9. Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.
  10. Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function: The ARIC Study.
  11. Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis.
  12. Association of Kidney Function With Incident Heart Failure: An Analysis of the Women's Health Initiative.
  13. Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure.

Abdominal CT and laboratory risk markersOnset of sepsis

Open figure ↗
19952000200520102015202020252026 · Glyph0.60.81.01.21.41.61.8Publication yearOdds Ratio*eGFR risk indexPrior hypertensionPrior diabetesLower serum albuminPrior hepatitis CBMI risk indexPrior splenectomyLower HDL cholesterolPrior coeliac diseaseHbA1c risk indexLymphocytes <1.1×10⁹/LSmoking risk indexLower LDL cholesterolCT-reported steatosisI87HepatobiliarypatternI25FluidaccumulationL84AzotemiaL87Coagulopathy /renalimpairmentL127CytopeniaL108CholestasisL91Low albuminL104Iron-deficiencyanaemiaI76BoweldistensionI17Advancedmalignancy /organ failurePUBLISHED LITERATURE · AUROC 0.673WITH GLYPH · AUROC 0.706(+4.9% relative improvement)● Represented in literature● Beyond literature markers△ Closest Phecode matchPowe et al.“Albumin andsepticemia”Kidney Int (477 cites)Ludvigsson et al.“Coeliac disease andsepsis”Gut (123 cites)Wang et al.“Chronic conditionsand sepsis”PLoS One (179 cites)Wang et al.“Obesity and sepsis”Obesity (107 cites)Edgren et al.“Splenectomy andsepsis”Ann Surg (81 cites)McDonald et al.“Kidney function andinfection”AJKD (80 cites)Guirgis et al.“Cholesterol andfuture sepsis”Crit Care (76 cites)Warny et al.“Lymphopenia andinfection”PLoS Med (184 cites)Lee et al.“Hepatitis andinfection”PLoS Med (10 cites)Balintescu et al.“Glycemic control andsepsis”Diabetes Care (44 cites)Ebrahimi et al.“NAFLD and severeinfection”CGH (33 cites)

* Adjusted for patient age, sex, and recorded race; per Discovery-site SD. N = 4,754 studies.

References (11)
  1. Septicemia in dialysis patients: incidence, risk factors, and prognosis.
  2. Coeliac disease and risk of sepsis.
  3. Chronic medical conditions and risk of sepsis.
  4. Obesity and risk of sepsis: a population-based cohort study.
  5. Splenectomy and the risk of sepsis: a population-based cohort study.
  6. CKD and the risk of acute, community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using electronic health records.
  7. Cholesterol levels and long-term rates of community-acquired sepsis.
  8. Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study.
  9. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
  10. Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.
  11. Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.